DOC

High Performance Liquid Chromatography gallbladder Capsule contents of baicalin_439

By Elsie Carter,2014-10-30 19:27
8 views 0
High Performance Liquid Chromatography gallbladder Capsule contents of baicalin_439

    High Performance Liquid Chromatography gallbladder Capsule contents of baicalin

     Author: Zhao Cuiyun Jia Yuan Li Chao Liu Yan Xin India

     Abstract Objective To study the choleretic Capsule baicalin method for the determination to develop quantitative quality control standards. Methods HPLC method for the preparation of the main drugs determination. Results The methodology of the system inspection and assay of three batches of samples to establish the product in the

    determination of baicalin method, the measured three batches of samples of the contents of baicalin were 9.18,9.71,9.40 mg / tablets, baicalin its linear range of 19.7 ~ 98.5 μg / ml,

    the regression equation: Y = 61 824X 75 898, r = 0.999. The average recovery was 100.3%, RSD 1.90%. Conclusion The established method has a specific, repeatable, no significant interference, etc., is to determine the gallbladder Capsule baicalin content in a more ideal way.

     Key words gallbladder capsule; high-performance liquid

    chromatography; baicalin

     Determination of Baicalin in Lidan Capsule by HPLC

     Abstract: ObjectiveTo study the method for determination of baicalin in Lidan Capsule and establish the pharmaceutical quality standard.MethodsThe main component of the pharmacy is

    detected by HPLC.ResultsThe contents of baicalin in three batches of sample were 9.18 mg / capsule, 9.17 mg / capsule and 9.40 mg / capsule, respectively.The regression equation was Y = 61824X 75898, r = 0.999.The average recovery was

    100.3%, RSD was 1.90%. ConclusionThe method is specific,

    reproducible and noninterfered.It is a better method for determination of baicalin in Lidan Capsule.

     Key words: Lidan Capsule; HPLC; Baicalin

     Gallbladder capsule is being developed by the new Chinese

    medicine, this product mainly by baicalin, cholic acid, HDCA and many other Chinese herbal medicines form. Jun Scutellaria-

    based Prescription drugs, which contain baicalin is the main active ingredient [1], for the development of a quantitative

    quality control standards of this drug with reference to relevant literature [2 ~ 5] in the determination of baicalin method, baicalin Lidan Capsule Assay carried out the study, through the methodology of systematic survey and assay of three batches of samples to establish the product of baicalin by HPLC method.

     An instrument and reagent

     United States Waters 600 high-performance liquid

    chromatography (600 Pump, 996 Photodiode Array Detector); column of Shimadzu shim-pack CLC-ODS, 6.0 mm × 150 mm; ultra-

    pure water; chromatography of pure methanol, and other reagents were analytically pure; baicalin reference substances were purchased in China's pharmaceutical and biological products.

     2 Methods and Results

     2.1 Preparation of sample solution

     2.1.1 Preparation for the test product solutions appropriate to take this product, and research fine, saying that taking 0.2 g, precision that set, plus 70% ethanol, 40 ml, reflux extraction 3 h, put cold filtration, the filtrate

    100 ml Liangping home in 70% ethanol with a small amount of sub-sub-washed containers and residues, filter into the same Liangping lotion, add 70% ethanol to scale, shake, as a solution for the test items.

     2.1.2 Preparation of reference substance solution to take

    60 ? vacuum drying 4 h the amount of baicalin reference substance buy 100 ml Liang Ping, the precision that as 19.70 mg, plus alcohol allows the dissolved and diluted to the scale, shake, as a reference substance stock solution; precise

    volume of 3 ml set to take 10 ml Liang Ping, add methanol to the scale, shake, as a reference substance solution, its concentration of 59.10 μg / ml.

     2.1.3 lack of preparation of Scutellaria blank solution and accurately according to the proportion of prescriptions

    taken except that skullcap herbs outside the 3-pin to simulate

    the preparation of this product technology and product solutions for the test preparation methods, made of skullcap missing blank solution.

     2.2 Chromatographic conditions and system suitability

    experiment octadecyl silane bonded silica gel as a filler; methanol -0.4% phosphoric acid solution (55:45) as mobile phase; flow rate of 1.0 ml / min; column temperature of 30 ? ; detection wavelength 280 nm. Number of theoretical

    plates according to the calculation of baicalin peak should not be less than 2 000.

     2.3 Determination

     2.3.1 The maximum absorption wavelength of the alternatives are sophisticated drawing reference substance solution and test products for the solution of 10 μl, into

    the sample, in the range of 200 ~ 370 nm to detect, depicts absorption diagram. The results showed that both at 280 nm at the maximum absorption peak detection wavelength was therefore determined to be 280 nm, and the "Chinese Pharmacopoeia" in

    2005 edition of Part ? HPLC determination of baicalin in the same wavelength.

     2.3.2 interference experiment, precision drawing a blank reference substance solution and test products for the solution and blank solution lacking the 10 μl, injection, and

    detected at 280 nm, results show that the reference substance solution and test products for the solution at the wavelength are maximum absorption, while the lack of Scutellaria blank solution at the wavelength were no obvious peaks appeared,

    indicating that under the conditions of the HPLC

    determination, the determination of baicalin was no significant interference. Figure 1 ~ 3. Reposted elsewhere in the paper for free download http://

     Figure 1 baicalin chromatography (abbreviated)

     2.3.3 Precision linear relationship and the standard curve the amount of reserves to take the above-mentioned

    reference substance solution 1,2,3,4,5 ml in 10 ml Liang Ping, add methanol to the scale, shake, their concentrations were 19.7,39.4, 59.1,78.8,98.5 μg / ml, more precise drawing

    samples of each 10 μl, injection of high-performance liquid

    chromatography, the measured peak area values. To peak area value of the vertical axis, sample volume (μg / ml) as

    abscissa, drawing the standard curve regression equation was:

    Y = 61 824X 75 898, r = 0.999, sample volume of 19.7 ~ 98.5 μ

    g / ml the scope of a good linear relationship. The results in Table 1.

     Figure 2 for the test materials chromatography (abbreviated)

     Figure 3 missing skullcap blank chromatography

    (abbreviated)

     2.3.4 Precision Precision drawing experiment were tested with the product solution and the reference substance solution of 10 μl, respectively, continuous nebulization five times the value of measured peak area. The results for the test

    items measured five times ? s = 3 288 247 ? 13 837.39, RSD

    0.42%, reference substance measured five times ? s = 308 888

    ? 20 200.83, RSD 0.66%.

     2.4 The stability of the experimental precision for the test items were drawn with the solution and reference

    substance solution of 10 μl, at intervals of 2 h were

    measured a second sample were measured five times, the peak area values in the determination of time, basically unchanged, within 8 h for the determination of test items five times ? s

    = 3 317 748 ? 26 737.84, RSD 0.81%, reference substance measured five times ? s = 3 038 888 ? 20 200.83, RSD 0.66%,

    indicating good stability.

     Table 1 reference substance measured results (omitted)

     2.5 repeated experiment to take the same group (20.05041

    million) Sample 6 copies, according to determination under the law, samples were measured in the content of baicalin, the results of six determinations, the average content of 31.78 mg / g, the RSD was 2.4% , indicating good repeatability.

     2.6 recovery experiment to take samples of five copies of the same batch, by adding 3.06 mg of baicalin (dubbed in the concentration of 1.02 mg / ml solution, accurate and adding 3.0 ml), according to the above method for the preparation of

    the test items sample solution and determine the content of calculate the recovery rate. The results in Table 2.

     Table 2 Addition recovery results (omitted)

     2.7 Determination of the samples were drawn precision reference substance solution and three groups for the solution of the test product 10 μl, into the liquid chromatograph to

    measure and calculate the various batches of samples the content of baicalin. The results in Table 3.

     Table 33 groups gallbladder Capsule Determination of

    baicalin in results (omitted)

     3 Discussion

     Methodology of the system through the investigation and determination of samples was established in the preparation of baicalin HPLC assay method, measured by three batches of samples of the contents of baicalin were 9.18,9.71,9.40 mg / tablets, sample collection rate was 100.3%, the largest coefficient of variation was 1.90%.

     The standard established by baicalin HPLC method for the determination, with specific, reproducible, no significant

    interference, etc., is to control the inherent quality of this product an ideal way.

     References

     [1] State Pharmacopoeia Commission. Chinese Pharmacopoeia, ? Department of [S]. Beijing: Chemical Industry Press, 2005:248.

     [2] Bao-Qin Wang. Chinese medicine quality standards and standards for material research [M]. Beijing: Chinese Medical Science and Technology Publishing House, 1994:226,260,276.

     [3] Fu Guilan. HPLC Determination of baicalin and compound preparation of the content of baicalin [J]. Chinese Journal of Traditional Chinese Medicine, 1994,19 (12): 731.

     [4] Guo, Li Zhang Wan, Jiang Xue-hua, et al. HPLC

    determination of 12 kinds of traditional Chinese medicine preparation in the baicalin [J]. Journal of Drug Analysis,

    1995,15 (5): 13.

     [5] Cheng-Yong Wu, Xue Shan Chun, Feng Zhongping, et al. Houbi Granule by High Performance Liquid Chromatography of baicalin content [J]. Chinese medicine, 1994,16 (9): 51. Reposted elsewhere on the free Paper Download Center http://

Report this document

For any questions or suggestions please email
cust-service@docsford.com